Minretumomab
Minretumomab (CC-49) is a murine monoclonal antibody against TAG-72 (tumor-associated glycoprotein 72) . Minretumomab is used in cancer and immunity research[1][2].
Product Specifications
CAS Number
195189-17-4
Product Name Alternative
CC-49
UNSPSC
12352203
Target
Mucin
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/minretumomab.html
Purity
97.37
Solubility
10 mM in DMSO
Smiles
[Minretumomab]
Molecular Weight
(146.06 kDa)
References & Citations
[1]Graves SS, et al. Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy. Clin Cancer Res. 2003 Sep 1;9 (10 Pt 1) :3712-21.|[2]Sheikh N. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute. Curr Opin Mol Ther. 2003 Aug;5 (4) :428-32.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1779-500 1x 500 µL
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (C8/1779R), 0.2mg/mL
Sign In for Pricing
View Details 
